Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: acetazolamide

Summary for Generic Name: acetazolamide

Drug Master File Entries: see list10
Suppliers: see list3
Therapeutic Class:Ophthalmic Agents

Pharmacology for Ingredient: acetazolamide

Clinical Trials for: acetazolamide

Tadalafil and Acetazolamide Versus Acetazolamide in Acute Mountain Sickness Prevention
Status: Completed Condition: Pulmonary Edema; Cerebral Edema

Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure
Status: Recruiting Condition: Heart Failure

Effect of Acetazolamide & Position in CSF Leakage and Collection and Wound Dehiscence
Status: Recruiting Condition: Tethered Cord Syndrome; Split Cord Malformation; Lipoma of Spinal Cord

A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular Dysfunction
Status: Recruiting Condition: Obstructive Sleep Apnea; Sleep-Disordered Breathing; Blood Pressure; Hypertension

Effectiveness of Acetazolamide in Reducing Paralysis of the Leg in Patients Undergoing Aortic Aneurysm Surgery Surgery
Status: Not yet recruiting Condition: Thoracic Aneurysm

Comparison of Temazepam and Acetazolamide to Treat Difficulty Sleeping at High Altitude
Status: Recruiting Condition: High-altitude Sleep Disturbance

Acetazolamide Facilitates Ventilator Weaning
Status: Recruiting Condition: Ventilator Weaning; Alkalosis, Metabolic

Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation.
Status: Recruiting Condition: Pulmonary Disease, Chronic Obstructive; Obesity Hypoventilation Syndrome; Metabolic Alkalosis

Acetazolamide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow
Status: Completed Condition: Headache; Migraine

Acetazolamide for the Prevention of High Altitude Illness: a Comparison of Dosing
Status: Recruiting Condition: Prophylaxis of Acute Mountain Sickness

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharms Inc
CAPSULE, EXTENDED RELEASE;ORAL090779Jul 14, 2011RXNo<disabled><disabled>
Zydus Pharms Usa Inc
CAPSULE, EXTENDED RELEASE;ORAL040904Dec 10, 2008RXNo<disabled><disabled>
Duramed Pharms Barr
CAPSULE, EXTENDED RELEASE;ORAL012945Approved Prior to Jan 1, 1982RXYes<disabled><disabled>
TABLET;ORAL083320Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology